Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine-specific demethylase 4E (KDM4E), also known as JMJD2E, is a histone lysine demethylase that removes methyl groups from lysine 9 on histone H3 (H3K9). It plays a role in epigenetic regulation by influencing chromatin structure and gene expression. KDM4E belongs to the KDM4/JMJD2 subfamily of histone demethylases and utilizes oxygen and 2-oxoglutarate as cofactors for its demethylation activity. It is being investigated as a potential therapeutic target, particularly in cancer.
Inhibition of histone demethylase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-specific demethylase 4E (KDM4E).